Natalia Sanchez, Michele Chen, Sally Ho, Holly Spinner, Jack Vagadori, Abigail Neiser, Kimberly Padilla, Madison Bristol, Elijah Winfield, Isabel Thorstad, Lauren D Gulley, Rachel G Lucas-Thompson, Laura Pyle, Talia Thompson, Doris E Estrada, Molly Basch, Marian Tanofsky-Kraff, Megan M Kelsey, Eleanor R Mackey, Lauren B Shomaker
BACKGROUND: Elevated depression symptoms have been associated with higher insulin resistance in adolescents, and consequently, greater risk for type 2 diabetes (T2D). Mindfulness-based intervention (MBI) may be suited for adolescents at risk for T2D given its potential to decrease depression and improve stress-related behavior/physiology underpinning insulin resistance. To prepare for a future multisite efficacy randomized controlled trial, a rigorous, multisite, pilot and feasibility study is needed to test this approach...
April 3, 2024: Contemporary Clinical Trials